Abeona Therapeutics Receives EU Orphan Drug Designation for ABO-201 Gene Therapy Program in Juvenile Batten … – Investing News Network (press release) (registration) (blog)
CNA Finance |
Abeona Therapeutics Receives EU Orphan Drug Designation for ABO-201 Gene Therapy Program in Juvenile Batten …
Investing News Network (press release) (registration) (blog) Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening rare genetic diseases, announced today that the European Medicines Agency (EMA) Committee for Orphan … Abeona Therapeutics (ABEO) ABO-201 Program Granted Orphan Drug Designation in Europe Abeona Therapeutics Inc. (ABEO) Analyst Coverage |
